unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/Overview.htm
UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/about-us.htm
UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. Our platform technologies from molecular and cellular engineering of high yield antibody and protein production of specific products by CHO cells are also being used to develop a line of biosimilar and biobetter versions of widely used protein and antibody drugs whose patents are about to expire. Additional re...
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/Ub-311.htm
UB-311 is a novel immunotherapeutic for the treatment of Alzheimer’s Disease (AD). The UBI vaccine employs the. Helper T cell technology and a particular site-specific epitope to target the amyloid-beta peptide. UB-311 has successfully completed clinical Phase I study, demonstrating safety and tolerability. UBI is initiating a Phase II study.
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/Hiv-vaccines.htm
UBI has two HIV vaccines in development. Our first product, UBI HIV-RC vaccine, is an investigational. Our second product, UBI HIV gp120, is an immunotherapy of HIV intended as a preventative vaccine for uninfected people and as an immunotherapeutic vaccine for infected people. Its primary active ingredient is an investigational. Immunogen induces an anti-HIV antibody response that blocks HIV from binding to the CD4 cell surface receptor, thereby inhibiting the initial step that leads to HIV infection.
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/Publications.htm
UBI Publications by Field. Review publication of UBITh technology and products. 1 Wang CY, Walfield AM. Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, and for veterinary applications. Vaccine 2005, 23:2049-2056. Aβ Immunotherapeutics (Alzheimer Disease). 1 Wang Y, Finstad CL, Walfield AM, Sia C, Sokoll KK, Chang TY, Fang XD, Hung CH, Birgit H-P and Windisch M. Site-specific UBITh. Severe Acute Respiratory Syndrome (SARS). Allergy, Including Vaccine. 3 Shen F, ...
ubiocmo.com
UBI Gruop CDMO Services, contract manufacturing organization (CMO) that provides services in bio CMO, biologics CMO, protein drugs CMO, and GMP manufacturing.
http://www.ubiocmo.com/sub5.html
Process development for biologics. Formulation development for pharmaceuticals. UBI group of companies. Business center:11049, 52E, No.7 Xin Yi Rd. Sec. 5, Taipei, Taiwan (R.O.C.). Tel: 886-2-8101-0101 # 1860. United Biomedical, Inc.,. Corporate Headquarters : United Biomedical, Inc. 25 Davids Drive Hauppauge, NY 11788. Tel: 886-2-8101-0101 # 1860. Contact: Dr. Roger Kuo, roger.kuo@ubi-pharma.com. Peter Tang, peter.tang@unitedbiopharma.com. Process development for biologics.
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/pipeline.htm
UBI has a robust pipeline of immunotherapeutic candidates and discovery programs built around our proprietary technology platforms and functional antigenic approach, in both human and animal applications.
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/Partnership.htm
In order to maximize the potential of our pipeline and bring our therapies to the market as quickly and efficiently as possible, UBI seeks pharmaceutical partners to facilitate the late-stage development and commercialization of our products in certain therapeutic areas. We welcome inquiries from interested companies wishing to discuss partnering opportunities with us.
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/Locations.htm
UBI is headquartered in Hauppauge, NY with operational divisions in Taipei and Hsin-Chu, Taiwan and Shanghai and Beijing, China. UBI’s China operations are located in 168,000 SF in Shanghai’s premier ZhiZhu Science Park. The new UBI-China base includes facilities for the manufacture of API peptides, for manufacturing human and animal vaccines and diagnostics, and for R&D support activities. This facility was approved by the Ministry of Agriculture, PRC for GMP compliance in 2007.
unitedbiomedical.com
United Biomedical, Inc.
http://www.unitedbiomedical.com/animal-health-vaccines.htm
The UBI platform technologies have proven equally applicable to animal healthcare and animal husbandry. Our animal health programs initially focus on the health and productivity of livestock, with a longer term plan to address health needs in companion animals. We have been developing a line of veterinary products in collaboration with national and international research centers. Our portfolio of veterinary products is listed below. Bo-Ta-Con: UBI LHRH vaccine for growth promotion and boar taint (swine).
